Advertisement Waters, Tecan enter clinical assay deal - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Waters, Tecan enter clinical assay deal

Waters Corporation has signed a deal with Tecan Group to combine Tecan's Freedom EVO liquid handling platform with Waters ACQUITY TQD liquid chromatograph/mass spectrometer (LC/MS/MS) to automate sample preparation.

Waters will make use of the technologies from both companies to combine into a single, fully-supported analytical system solution that helps laboratories increase assay throughput and efficiency, improve profitability, and drive down overall assay costs.

Waters Division clinical marketing director Patrick Martell said the multi-step process of preparing samples for LC/MS/MS analyses would provide an opportunity for improvement in many laboratories.

"Combining sample preparation and analysis in a single unified platform facilitates the entire assay process and streamlines analyses significantly," Martell added.